Emergent Biosolutions (EBS) 27.71 $EBS
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016
ACCESSWIRE - 42 mins ago
NEW YORK, NY / ACCESSWIRE / September 8, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court District of Maryland on behalf of those who purchased shares of Emergent Biosolutions, Inc. ("Emergent" or the "Company"
(NYSE: EBS) during the period between January 11, 2016 and June 21, 2016, inclusive (the "Class Period".
EBS: 27.71 (+0.02)
INVESTOR ALERT: Hagens Berman Reminds Emergent Biosolutions, Inc. (NYSE: EBS) Investors of September 19, 2016 Lead Plaintiff Deadline
GlobeNewswire - 1 hr 42 mins ago
Hagens Berman Sobol Shapiro LLP reminds investors in Emergent Biosolutions, Inc. (NYSE:EBS) that the Lead Plaintiff Deadline is September 19, 2016 in the securities class action pending in the United States District Court for the District of Maryland.
EBS: 27.71 (+0.02)
UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Sep 07, 3:50PM CDT
IRVINE, CA / ACCESSWIRE / September 7, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
Lifshitz & Miller Law Firm Announces Investigation of Accuride Corporation, Albany Molecular Research Inc., Emergent BioSolutions, Inc., Flowers Foods, Inc., Orbital ATK, Inc., Quorum Health Corp., Stericycle, Inc., and SunPower Corporation
PR Newswire - Wed Sep 07, 3:06PM CDT
Accuride Corporation (ACW)
EBS: 27.71 (+0.02), ACW: 2.58 (unch), SRCL: 82.98 (+0.19), SPWR: 9.83 (-0.38), QHC: 7.18 (+0.17), OA: 76.33 (+0.49), AMRI: 15.16 (+0.12), FLO: 15.03 (+0.01)
INVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBS
PR Newswire - Wed Sep 07, 12:23PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Emergent BioSolutions, Inc. common stock (NYSE: EBS) from January 11, 2016 through June 21, 2016, both dates inclusive (the "Class Period" of the important September 19, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Emergent BioSolutions investors under the federal securities laws.
EBS: 27.71 (+0.02)
UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Sep 06, 10:22AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 6, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
EBS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016
BusinessWire - Tue Sep 06, 9:21AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Maryland on behalf of investors who purchased Emergent Biosolutions Inc. (NYSE:EBS) securities between January 11, 2016 and June 21, 2016.
EBS: 27.71 (+0.02)
DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Sat Sep 03, 4:50AM CDT
IRVINE, CA / ACCESSWIRE / September 3, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
EMERGENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS
GlobeNewswire - Fri Sep 02, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 19, 2016 to file lead plaintiff applications in a securities class action lawsuit against Emergent BioSolutions, Inc. (NYSE:EBS), if they purchased the Company's securities between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the District of Maryland.
EBS: 27.71 (+0.02)
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Sep 02, 10:21AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 2, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016
GlobeNewswire - Fri Sep 02, 9:10AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court District of Maryland on behalf of those who purchased shares of Emergent Biosolutions, Inc. ("Emergent" or the "Company" (NYSE:EBS) during the period between January 11, 2016 and June 21, 2016, inclusive (the "Class Period".
EBS: 27.71 (+0.02)
APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Sep 01, 3:53PM CDT
IRVINE, CA / ACCESSWIRE / September 1, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Emergent BioSolutions Inc. Of Upcoming Deadline
GlobeNewswire - Thu Sep 01, 2:10PM CDT
Rigrodsky & Long, P.A.:
EBS: 27.71 (+0.02)
EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 31, 4:28PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 31, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBS
GlobeNewswire - Wed Aug 31, 2:51PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Emergent BioSolutions, Inc. common stock (NYSE:EBS) from January 11, 2016 through June 21, 2016, both dates inclusive (the "Class Period" of the important September 19, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Emergent BioSolutions investors under the federal securities laws.
EBS: 27.71 (+0.02)
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 31, 1:19PM CDT
IRVINE, CA / ACCESSWIRE / August 31, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions, Inc. Investors and Encourages Investors to Contact the Firm
BusinessWire - Wed Aug 31, 11:50AM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) securities between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". Emergent investors have until September 19, 2016 to file a lead plaintiff motion.
EBS: 27.71 (+0.02)
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 31, 10:10AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 31, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline.
EBS: 27.71 (+0.02)
EBS INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016
PR Newswire - Wed Aug 31, 9:08AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Maryland on behalf of investors who purchased Emergent Biosolutions Inc. (NYSE: EBS) securities between January 11, 2016 and June 21, 2016.
EBS: 27.71 (+0.02)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016
ACCESSWIRE - 42 mins ago
NEW YORK, NY / ACCESSWIRE / September 8, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court District of Maryland on behalf of those who purchased shares of Emergent Biosolutions, Inc. ("Emergent" or the "Company"
(NYSE: EBS) during the period between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". EBS: 27.71 (+0.02)
INVESTOR ALERT: Hagens Berman Reminds Emergent Biosolutions, Inc. (NYSE: EBS) Investors of September 19, 2016 Lead Plaintiff Deadline
GlobeNewswire - 1 hr 42 mins ago
Hagens Berman Sobol Shapiro LLP reminds investors in Emergent Biosolutions, Inc. (NYSE:EBS) that the Lead Plaintiff Deadline is September 19, 2016 in the securities class action pending in the United States District Court for the District of Maryland.
EBS: 27.71 (+0.02)
UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Sep 07, 3:50PM CDT
IRVINE, CA / ACCESSWIRE / September 7, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
Lifshitz & Miller Law Firm Announces Investigation of Accuride Corporation, Albany Molecular Research Inc., Emergent BioSolutions, Inc., Flowers Foods, Inc., Orbital ATK, Inc., Quorum Health Corp., Stericycle, Inc., and SunPower Corporation
PR Newswire - Wed Sep 07, 3:06PM CDT
Accuride Corporation (ACW)
EBS: 27.71 (+0.02), ACW: 2.58 (unch), SRCL: 82.98 (+0.19), SPWR: 9.83 (-0.38), QHC: 7.18 (+0.17), OA: 76.33 (+0.49), AMRI: 15.16 (+0.12), FLO: 15.03 (+0.01)
INVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBS
PR Newswire - Wed Sep 07, 12:23PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Emergent BioSolutions, Inc. common stock (NYSE: EBS) from January 11, 2016 through June 21, 2016, both dates inclusive (the "Class Period"
of the important September 19, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Emergent BioSolutions investors under the federal securities laws. EBS: 27.71 (+0.02)
UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Sep 06, 10:22AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 6, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
EBS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016
BusinessWire - Tue Sep 06, 9:21AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Maryland on behalf of investors who purchased Emergent Biosolutions Inc. (NYSE:EBS) securities between January 11, 2016 and June 21, 2016.
EBS: 27.71 (+0.02)
DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Sat Sep 03, 4:50AM CDT
IRVINE, CA / ACCESSWIRE / September 3, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
EMERGENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS
GlobeNewswire - Fri Sep 02, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 19, 2016 to file lead plaintiff applications in a securities class action lawsuit against Emergent BioSolutions, Inc. (NYSE:EBS), if they purchased the Company's securities between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the District of Maryland. EBS: 27.71 (+0.02)
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Sep 02, 10:21AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 2, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016
GlobeNewswire - Fri Sep 02, 9:10AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court District of Maryland on behalf of those who purchased shares of Emergent Biosolutions, Inc. ("Emergent" or the "Company"
(NYSE:EBS) during the period between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". EBS: 27.71 (+0.02)
APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Sep 01, 3:53PM CDT
IRVINE, CA / ACCESSWIRE / September 1, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Emergent BioSolutions Inc. Of Upcoming Deadline
GlobeNewswire - Thu Sep 01, 2:10PM CDT
Rigrodsky & Long, P.A.:
EBS: 27.71 (+0.02)
EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 31, 4:28PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 31, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBS
GlobeNewswire - Wed Aug 31, 2:51PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Emergent BioSolutions, Inc. common stock (NYSE:EBS) from January 11, 2016 through June 21, 2016, both dates inclusive (the "Class Period"
of the important September 19, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Emergent BioSolutions investors under the federal securities laws. EBS: 27.71 (+0.02)
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 31, 1:19PM CDT
IRVINE, CA / ACCESSWIRE / August 31, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions, Inc. Investors and Encourages Investors to Contact the Firm
BusinessWire - Wed Aug 31, 11:50AM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Emergent BioSolutions, Inc. ("Emergent" or the "Company"
(NYSE: EBS) securities between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". Emergent investors have until September 19, 2016 to file a lead plaintiff motion. EBS: 27.71 (+0.02)
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 31, 10:10AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 31, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline. EBS: 27.71 (+0.02)
EBS INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016
PR Newswire - Wed Aug 31, 9:08AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Maryland on behalf of investors who purchased Emergent Biosolutions Inc. (NYSE: EBS) securities between January 11, 2016 and June 21, 2016.
EBS: 27.71 (+0.02)
